Results 121 to 130 of about 24,102 (218)

Menopausal hormone therapy after ovarian cancer: A 10‐year survival analysis in premenopausal women

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1468-1479, August 2026.
Among premenopausal women surgically treated for ovarian cancer, no difference in 10‐year overall survival was observed between postoperative MHT users and non‐users. Young ovarian cancer survivors should be recommended MHT after surgically induced menopause.
Åsa Ehlin von Kartaschew   +4 more
wiley   +1 more source

Effect of opportunistic salpingectomy at hysterectomy on anti‐Müllerian hormone: A substudy of a randomized trial

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 8, Page 1480-1489, August 2026.
Noninferiority of opportunistic salpingectomy during benign hysterectomy compared with hysterectomy‐only concerning ovarian function measured by anti‐Müllerian hormone 1 year after surgery could not be declared. Studies with clinical outcomes related to ovarian function are still needed.
Anna Darelius   +3 more
wiley   +1 more source

Various hysterosalpingography findings of female genital tuberculosis: A case series

open access: yesIranian Journal of Reproductive Medicine, 2013
Background: Genital tuberculosis is a chorionic disease and mostly occurs by haematogenous spread from extra genital source like lungs, peritoneum, lymph nodes and bones. Transmission through a sexual intercourse is also possible.
Nargess Afzali   +2 more
doaj  

Mutational Signature‐Based Biomarker for Phase II Trial of Olaparib Maintenance in Advanced High‐Grade Ovarian Cancer

open access: yesCancer Science, Volume 117, Issue 8, Page 2259-2273, August 2026.
A whole‐exome sequencing–based mutational signature biomarker (MSBM) identified an HRD‐enriched population in advanced ovarian cancer. In a phase II trial, olaparib maintenance suggested clinically meaningful PFS benefit without bevacizumab, supporting MSBM as a complementary HRD assessment approach.
Katsutoshi Oda   +20 more
wiley   +1 more source

Estrogen and Progesterone Receptor Immunoexpression in Fallopian Tubes among Postmenopausal Women Based on Time since the Last Menstrual Period. [PDF]

open access: yesInt J Environ Res Public Health, 2021
Brodowska A   +7 more
europepmc   +1 more source

MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy

open access: yesCancer Science, Volume 117, Issue 8, Page 2085-2097, August 2026.
MTAP deletion creates a therapeutically actionable metabolic vulnerability through MTA accumulation and PRMT5 dependency. This review summarizes the biochemical basis of MTAP‐directed synthetic lethality, emerging PRMT5/MAT2A inhibitors, clinicogenomic features of MTAP‐deleted tumors, and future strategies for precision oncology.
Hiroaki Ikushima, Hidenori Kage
wiley   +1 more source

Pathological studies on fallopian tube in relation to uterine lesions and ovarian abnormalities

open access: yesJournal of Veterinary Medical Research, 2010
A total number of 50 genital tracts were collected from cows slaughtered at “Belefia” abattoir in “Beni-Suef” governorate, Egypt. The genitalia were inspected grossly and the ovarian activity was noticed.
E. A. Mahdy
doaj  

Torsion of the fallopian tube.

open access: yesSouth African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1998
No ...
openaire   +2 more sources

Improved endoscope for imaging and cell collection in the fallopian tubes. [PDF]

open access: yesBiophotonics Discov
Gálvez D   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy